Product Categories
Country: | China |
---|---|
Tel: | 00-13720134139 +86 -0-15871494362 |
Mobile: | 13720134139 |
E-mail: | |
QQ: | |
Skype: | Chat Now! |
Product Name | MF | CAS | Details |
---|
3-Glycidoxy propyl trimethoxy silane | C9H20O5Si | 2530-83-8 | Details |
4-Bromo-5-methoxypicolinaldehyde | C7H6BrNO2 | 1289092-48-3 | Details |
2-(3,4-Difluorophenyl)oxirane | C8H6F2O | 111991-13-0 | Details |
ETA | C6H14ClNO | 3033-77-0 | Details |
Difluoromethyl 2-pyridyl sulfone | C6H5F2NO2S | 1219454-89-3 | Details |
(4-Fluoro-3-methoxy-phenyl)-methyl-amine | C8H10FNO | 904321-01-3 | Details |
2-Bromo-5-methylbenzenethiol | C7H7BrS | 19693-10-8 | Details |
6-(Trifluoromethyl)benzo[b]thiophen-3-amine | C9H6F3NS | 165108-01-0 | Details |
7-Bromo-4-chloro-8-methylquinazoline | C9H6BrClN2 | 1592956-60-9 | Details |
3-Methylquinoline-2-carbonitrile | C11H8N2 | 19051-05-9 | Details |
4,7-Dihydroxycoumarin | C9H6O4 | 1983-81-9 | Details |
4,7-dichloro-1H-imidazo[4,5-d]pyridazine | C5H2Cl2N4 | 17998-43-5 | Details |
5,6-dihydro-1H-imidazo[4,5-d]pyridazine-4,7-dione | C5H4N4O2 | 6293-09-0 | Details |
N-((4aR,7R,8R,8aS)-6,8-dihydroxy-2-phenylhexahydropyrano[3,2-d][1,3]dioxin-7-yl)butyramide | C17H23NO6 | 15767-89-2 | Details |
N-((3R,4R,5S,6R)-2,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)butyramide | C10H19NO6 | 5441-12-3 | Details |
Benzoic acid, 4-bromo-2-(methylamino)-, methyl ester | C9H10BrNO2 | 1367708-38-0 | Details |
(S)-4-amino-2-(1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl) ethyl)isoindoline-1,3-dione | C20H22N2O6S | 635705-72-5 | Details |
Apremilast Impurity N | C19H18N2O7S | 1384439-79-5 | Details |
Apremilast Impurity E | C20H20N2O8S | 2095036-40-9 | Details |
Apremilast Impurity 20;Apremilast Impurity TTN | C30H27N3O9S | 1802246-60-1 | Details |
(S)-N-(2-(1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)- 1,3-dioxoisoindolin-4-yl)formamide | C21H22N2O7S | 2077897-94-8 | Details |
(S)-N-(2-(1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-5-yl)acetamide | C22H24N2O7S | 2201974-01-6 | Details |
Apremilast | C20H20N2O7S | 1384967-20-7 | Details |
1H-Isoindole-1,3(2H)-dione, 5-amino-2-[1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]- | C20H22N2O6S | 253168-81-9 | Details |
1H-Isoindole-1,3(2H)-dione, 2-[1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-5-nitro- | C20H20N2O8S | 253168-80-8 | Details |
Acetate Impurity | C22H27NO4 | 219718-02-2 | Details |
[1,1'-Biphenyl]-4-propanoic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-, ethyl ester, (αR)- | C22H27NO4 | 1848219-25-9 | Details |
Dimethyl Impurity | C21H22N2O7S | 1809089-51-7 | Details |
Apremilast Impurity TNA | C22H26N2O8S | 1809170-71-5 | Details |
OWIZSBUSCSIZSA-SFHVURJKSA-N | C20H23NO3 | 182192-86-5 | Details |
tert-Butyl(S)-(1-([1,1'-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbamate | C20H25NO3 | 153037-40-2 | Details |
Methyl5-bromo-2-(methylamino)benzoate | C9H10BrNO2 | 33922-96-2 | Details |
C-(1H-pyrazol-4-yl)methylamine | C4H7N3 | 37599-59-0 | Details |
2-Chloro-N-cyclopropylacetamide | C5H8ClNO | 19047-31-5 | Details |
Methyl3-aminothieno[2,3-b]pyridine-2-carboxylate | C9H8N2O2S | 111042-89-8 | Details |
1,2-Epoxy-4-vinylcyclohexane | C8H12O | 106-86-5 | Details |
2-Bromo-5-methoxybenzenethiol | C7H7BrOS | 13993-51-6 | Details |
(2S,3S)-3-Boc-amino-1,2-epoxy-4-phenylbutane(AtazanavirImpurity) | C15H21NO3 | 98737-29-2 | Details |
(3aR,4S,7R,7aS)-rel-3a,4,7,7a-Tetrahydro-4,7-epoxyisobenzofuran-1,3-dione | C8H6O4 | 6118-51-0 | Details |
(S)-(+)-Benzyl glycidyl ether | C10H12O2 | 16495-13-9 | Details |
Glycidyl methacrylate | C7H10O3 | 106-91-2 | Details |
3-Glycidyloxypropyl(dimethoxy)methylsilane | C9H20O4Si | 65799-47-5 | Details |
(R)-2-phenyloxirane | C8H8O | 20780-53-4 | Details |
3-Methylquinoline-2-carboxylic acid | C11H9NO2 | 92513-28-5 | Details |
Methyl 3-Methylquinoline-2-carboxylate | C12H11NO2 | 53821-46-8 | Details |
GRT6005 | C24H27FN2O | 863513-91-1 | Details |
DMPG | C34H66NaO10P | 67232-80-8 | Details |
dspe-peg 2000 | C45H87NNaO11P | 147867-65-0 | Details |
N,N'-bis-(2-Chloroethyl)urea | C5H10Cl2N2O | 2214-72-4 | Details |
DSPE | C41H82NO8P | 1069-79-0 | Details |
Ifosfamide impurity F CRS | C5H10Cl2NO2P | 40722-73-4 | Details |
3-[(2-Chloroethyl)amino]-1-propanol Hydrochloride | C5H13Cl2NO | 40722-80-3 | Details |
1-Propanol, 3-[(2-chloroethyl)amino]- | C5H12ClNO | 40722-99-4 | Details |
Isophosphamide | C7H15Cl2N2O2P | 3778-73-2 | Details |
DSPC | C44H88NO8P | 816-94-4 | Details |
KRAS G12D inhibitor 5 | C31H31ClF2N6O2 | 2621928-53-6 | Details |
Bulevirtide | 2012558-47-1 | Details |
Hydroxychloroquine sulfate | C18H28ClN3O5S | 747-36-4 | Details |
T-5224 | C29H27NO8 | 530141-72-1 | Details |
Poziotinib (HM781-36B) | C23H21Cl2FN4O3 | 1092364-38-9 | Details |
CK 1827452 | C20H24FN5O3 | 873697-71-3 | Details |
Telavancin Hydrochloride | C80H107Cl3N11O27P | 560130-42-9 | Details |
Quizartinib dihydrochloride | C29H33ClN6O4S | 1132827-21-4 | Details |
2-Naphthalenol, 4-[4-(3,8-diazabicyclo[3.2.1]oct-3-yl)-5,8-dihydro-2-[[1-(4-morpholinylmethyl)cyclopropyl]methoxy]pyrido[3,4-d]pyrimidin-7(6H)-yl]-5-iodo- | C32H39IN6O3 | 2648221-12-7 | Details |
FK866(APO866,Daporinad) | C24H29N3O2 | 658084-64-1 | Details |
Ruxolitinib Phosphate | C17H21N6O4P | 1092939-17-7 | Details |
INCB-018424 | C17H18N6 | 941678-49-5 | Details |
Leniolisib | C21H25F3N6O2 | 1354690-24-6 | Details |
FMF-04-159-2 | C28H30Cl3N7O5S | 2364489-81-4 | Details |
Brincidofovir | C27H52N3O7P | 444805-28-1 | Details |
NSC5844 | C20H16Cl2N4 | 140926-75-6 | Details |
Poziotinib Hydrochloride | C23H22Cl3FN4O3 | 1429757-68-5 | Details |
Pyridoxalisonicotinoylhydrazone | C14H14N4O3 | 737-86-0 | Details |
JNJ-7706621 | C15H12F2N6O3S | 443797-96-4 | Details |
Tofersen | 2088232-70-4 | Details |
Trofinetide | C13H21N3O6 | 853400-76-7 | Details |
BI 1015550 | C20H26ClN6O2S- | 1423719-30-5 | Details |
Gefitinib-based PROTAC 3 | C47H57ClFN7O8S | 2230821-27-7 | Details |
NTP-42 | C25H23F2N3O5S | 2055599-51-2 | Details |
3-Phenanthrenebutanoicacid | C18H16O2 | 13728-56-8 | Details |
SN-38 Glucuronide | C28H28N2O11 | 121080-63-5 | Details |
Erythromycin Cyclocarbonate | C38H65NO14 | 55224-05-0 | Details |
KRASG12Dinhibitor13 | C31H33F2N7O3 | 2648552-62-7 | Details |
Methanone, [2-(1H-indol-3-yl)-1H-imidazol-5-yl](3,4,5-trimethoxyphenyl)- | C21H19N3O4 | 1332881-26-1 | Details |
Donanemab | 1931944-80-7 | Details |
Erdafitinib | C25H30N6O2 | 1346242-81-6 | Details |
AC220 | C29H32N6O4S | 950769-58-1 | Details |
RG120 | C28H22ClF3N6O3 | 1448347-49-6 | Details |
Pralsetinib | C27H32FN9O2 | 2097132-94-8 | Details |
Lecanemab | 1260393-98-3 | Details |
Molnupiravir | C13H19N3O7 | 2492423-29-5 | Details |
BRD0639 | C21H22ClN5O4S | 2760881-74-9 | Details |
Hypericin | C30H16O8 | 548-04-9 | Details |
Benzene, 4-bromo-1-chloro-2-[[4-[2-(cyclopropyloxy)ethoxy]phenyl]methyl]- | C18H18BrClO2 | 1118567-45-5 | Details |
dapagliflozin | C21H25ClO6 | 461432-26-8 | Details |
1-benzhydrylazetidine-3-carbaldehyde | C17H17NO | 72351-37-2 | Details |
1-benzhydryl-3-bromoazetidine | C16H16BrN | 36476-84-3 | Details |
1-benzhydrylazetidin-3-yl methanesulfonate | C17H19NO3S | 33301-41-6 | Details |
Bexagliflozin | C24H29ClO7 | 1118567-05-7 | Details |
Ethanol, 2-[[4-[(7-chloro-4-quinolinyl)amino]pentyl]ethylamino]-, 1-acetate | C20H28ClN3O2 | 47493-14-1 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 |